The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Development of a multiple sclerosis functional composite as a clinical trial outcome measure
Abstract
The primary clinical outcome measure for evaluating multiple sclerosis in clinical trials has been Kurtzke's expanded disability status scale (EDSS). New therapies appear to favourably impact the course of multiple sclerosis and render continued use of placebo control groups more difficult. Consequently, future trials are likely to compare active treatment groups which will most probably require increased sample sizes in order to detect therapeutic efficacy. Because more responsive outcome measures will be needed for active arm comparison studies, the National Multiple Sclerosis Society's Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis appointed a Task Force that was charged with developing improved clinical outcome measures. This Task Force acquired contemporary clinical trial and historical multiple sclerosis data for meta-analyses of primary and secondary outcome assessments to provide a basis for recommending a new outcome measure. A composite measure encompassing the major clinical dimensions of arm, leg and cognitive function was identified and termed the multiple sclerosis functional composite (MSFC). The MSFC consists of three objective quantitative tests of neurological function which are easy to administer. Change in this MSFC over the first year of observation predicted subsequent change in the EDSS, suggesting that the MSFC is more sensitive to change than the EDSS. This paper provides details concerning the development and testing of the MSFC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
Kurtzke, J. F. (1983) · Neurology · doi:10.1212/wnl.33.11.1444 · Cited by 15,011
Practical Nonparametric Statistics
Groggel, D. J. (2000) · Technometrics · doi:10.1080/00401706.2000.10486067 · Cited by 11,041
Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosis
Jacobs, L. D., Cookfair, D. L., Rudick, R. A., Herndon, R. M., Richert, J. R., Salazar, A. M., Fischer, J. S., Goodkin, D. E., Granger, C. V., Simon, J. H., et al. (1996) · Annals of Neurology · doi:10.1002/ana.410390304 · Cited by 2,450
Paced Auditory Serial-Addition Task: A Measure of Recovery from Concussion
Gronwall, D. M. A. (1977) · Perceptual and Motor Skills · doi:10.2466/pms.1977.44.2.367 · Cited by 2,395
Cognitive dysfunction in multiple sclerosis.: I. Frequency, patterns, and prediction
Rao, S. M., Leo, G. J., Bernardin, L., & Unverzagt, F. (1991) · Neurology · doi:10.1212/wnl.41.5.685 · Cited by 2,110
Adult Norms for the Box and Block Test of Manual Dexterity
Mathiowetz, V., Volland, G., Kashman, N., & Weber, K. (1985) · The American Journal of Occupational Therapy · doi:10.5014/ajot.39.6.386 · Cited by 2,105
Johnson, K. P., Brooks, B. R., Cohen, J. A., Ford, C. C., Goldstein, J., Lisak, R. P., Myers, L. W., Panitch, H. S., Rose, J. W., Schiffer, R. B., et al. (1995) · Neurology · doi:10.1212/wnl.45.7.1268 · Cited by 1,898
Practical Nonparametric Statistics (2nd ed).
Groeneveld, R. A., & Conover, W. J. (1981) · Journal of the American Statistical Association · doi:10.2307/2287607 · Cited by 1,849
WEINSHENKER, B. G., BASS, B., RICE, G. P. A., NOSEWORTHY, J., CARRIERE, W., BASKERVILLE, J., & EBERS, G. C. (1989) · Brain · doi:10.1093/brain/112.1.133 · Cited by 1,452
The natural history of multiple sclerosis:a geographically based study
Cottrell, D. A., Kremenchutzky, M., Rice, G. P. A., Koopman, W. J., Hader, W., Baskerville, J., & Ebers, G. C. (1999) · Brain · doi:10.1093/brain/122.4.625 · Cited by 1,163
Cited by
Cohen, J. A., Coles, A. J., Arnold, D. L., Confavreux, C., Fox, E. J., Hartung, H.-P., Havrdova, E., Selmaj, K. W., Weiner, H. L., Fisher, E., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61769-3 · Cited by 1,205
Coles, A. J., Twyman, C. L., Arnold, D. L., Cohen, J. A., Confavreux, C., Fox, E. J., Hartung, H.-P., Havrdova, E., Selmaj, K. W., Weiner, H. L., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61768-1 · Cited by 1,198
Self-citationMuro-de-la-Herran, A., Garcia-Zapirain, B., & Mendez-Zorrilla, A. (2014) · Sensors · doi:10.3390/s140203362 · Cited by 1,172
The Multiple Sclerosis Impact Scale (MSIS-29): A new patient-based outcome measure
Hobart, J. (2001) · Brain · doi:10.1093/brain/124.5.962 · Cited by 1,120
Fischer, J. S., Rudick, R. A., Cutter, G. R., Reingold, S. C., & National MS Society Clinical Outcomes Assessment Task Force (1999) · Multiple Sclerosis Journal · doi:10.1177/135245859900500409 · Cited by 993
Self-citationMultiple Sclerosis Severity Score: Using disability and disease duration to rate disease severity
Roxburgh, R. H. S. R., Seaman, S. R., Masterman, T., Hensiek, A. E., Sawcer, S. J., Vukusic, S., Achiti, I., Confavreux, C., Coustans, M., le Page, E., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000156155.19270.f8 · Cited by 963
The Preclinical Alzheimer Cognitive Composite: Measuring Amyloid-Related Decline
Donohue, M. C., Sperling, R. A., Salmon, D. P., Rentz, D. M., Raman, R., Thomas, R. G., Weiner, M., & Aisen, P. S. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.803 · Cited by 860
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking
Teunissen, C. E., Petzold, A., Bennett, J. L., Berven, F. S., Brundin, L., Comabella, M., Franciotta, D., Frederiksen, J. L., Fleming, J. O., Furlan, R., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c47cc2 · Cited by 845
Benedict, R. H., DeLuca, J., Phillips, G., LaRocca, N., Hudson, L. D., Rudick, R., & Multiple Sclerosis Outcome Assessments Consortium (2017) · Multiple Sclerosis Journal · doi:10.1177/1352458517690821 · Cited by 839
Primary-progressive multiple sclerosis
Miller, D. H., & Leary, S. M. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70243-0 · Cited by 818
Minimal Neuropsychological Assessment of MS Patients: A Consensus Approach
Benedict, R. H. B., Fischer, J. S., Archibald, C. J., Arnett, P. A., Beatty, W. W., Bobholz, J., Chelune, G. J., Fisk, J. D., Langdon, D. W., Caruso, L., et al. (2002) · The Clinical Neuropsychologist · doi:10.1076/clin.16.3.381.13859 · Cited by 659
Relation of Visual Function to Retinal Nerve Fiber Layer Thickness in Multiple Sclerosis
FISHER, J., JACOBS, D., MARKOWITZ, C., GALETTA, S., VOLPE, N., NANOSCHIAVI, M., BAIER, M., FROHMAN, E., WINSLOW, H., & FROHMAN, T. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2005.10.040 · Cited by 658
Meyer-Moock, S., Feng, Y.-S., Maeurer, M., Dippel, F.-W., & Kohlmann, T. (2014) · BMC Neurology · doi:10.1186/1471-2377-14-58 · Cited by 639
Penner, I., Raselli, C., Stöcklin, M., Opwis, K., Kappos, L., & Calabrese, P. (2009) · Multiple Sclerosis Journal · doi:10.1177/1352458509348519 · Cited by 593
Intermittent Fasting Confers Protection in CNS Autoimmunity by Altering the Gut Microbiota
Cignarella, F., Cantoni, C., Ghezzi, L., Salter, A., Dorsett, Y., Chen, L., Phillips, D., Weinstock, G. M., Fontana, L., Cross, A. H., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.05.006 · Cited by 568
Heesen, C., Böhm, J., Reich, C., Kasper, J., Goebel, M., & Gold, S. (2008) · Multiple Sclerosis Journal · doi:10.1177/1352458508088916 · Cited by 521
The Nine-Hole Peg Test as a manual dexterity performance measure for multiple sclerosis
Feys, P., Lamers, I., Francis, G., Benedict, R., Phillips, G., LaRocca, N., Hudson, L. D., Rudick, R., & Multiple Sclerosis Outcome Assessments Consortium (2017) · Multiple Sclerosis Journal · doi:10.1177/1352458517690824 · Cited by 516
Kappos, L., Freedman, M. S., Polman, C. H., Edan, G., Hartung, H.-P., Miller, D. H., Montalbán, X., Barkhof, F., Radü, E.-W., Bauer, L., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61194-5 · Cited by 502
Thalamic atrophy and cognition in multiple sclerosis
Houtchens, M. K., Benedict, R. H. B., Killiany, R., Sharma, J., Jaisani, Z., Singh, B., Weinstock-Guttman, B., Guttmann, C. R. G., & Bakshi, R. (2007) · Neurology · doi:10.1212/01.wnl.0000276992.17011.b5 · Cited by 496
Segal, B. M., Constantinescu, C. S., Raychaudhuri, A., Kim, L., Fidelus-Gort, R., & Kasper, L. H. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70173-x · Cited by 479
Practice effects in healthy adults: A longitudinal study on frequent repetitive cognitive testing
Bartels, C., Wegrzyn, M., Wiedl, A., Ackermann, V., & Ehrenreich, H. (2010) · BMC Neuroscience · doi:10.1186/1471-2202-11-118 · Cited by 444
Chataway, J., Schuerer, N., Alsanousi, A., Chan, D., MacManus, D., Hunter, K., Anderson, V., Bangham, C. R. M., Clegg, S., Nielsen, C., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62242-4 · Cited by 443
Effect of relapses on development of residual deficit in multiple sclerosis
Lublin, F. D., Baier, M., & Cutter, G. (2003) · Neurology · doi:10.1212/01.wnl.0000096175.39831.21 · Cited by 421
Self-citationMotl, R. W., Cohen, J. A., Benedict, R., Phillips, G., LaRocca, N., Hudson, L. D., Rudick, R., & Multiple Sclerosis Outcome Assessments Consortium (2017) · Multiple Sclerosis Journal · doi:10.1177/1352458517690823 · Cited by 407
Benefit of interferon β-1a on MSFC progression in secondary progressive MS
Cohen, J. A., Cutter, G. R., Fischer, J. S., Goodman, A. D., Heidenreich, F. R., Kooijmans, M. F., Sandrock, A. W., Rudick, R. A., Simon, J. H., Simonian, N. A., et al. (2002) · Neurology · doi:10.1212/wnl.59.5.679 · Cited by 402
Self-citationZamboni, P., Galeotti, R., Menegatti, E., Malagoni, A. M., Gianesini, S., Bartolomei, I., Mascoli, F., & Salvi, F. (2009) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2009.07.096 · Cited by 374
Kappos, L., Freedman, M. S., Polman, C. H., Edan, G., Hartung, H.-P., Miller, D. H., Montalbán, X., Barkhof, F., Radü, E.-W., Metzig, C., et al. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70237-6 · Cited by 369
Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis
Comi, G., Jeffery, D., Kappos, L., Montalban, X., Boyko, A., Rocca, M. A., & Filippi, M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1104318 · Cited by 364
A review about the impact of multiple sclerosis on health-related quality of life
Benito-León, J., Manuel Morales, J., Rivera-Navarro, J., & Mitchell, A. J. (2003) · Disability and Rehabilitation · doi:10.1080/09638280310001608591 · Cited by 348
Benedict, R. H., Munschauer, F., Linn, R., Miller, C., Murphy, E., Foley, F., & Jacobs, L. (2003) · Multiple Sclerosis Journal · doi:10.1191/1352458503ms861oa · Cited by 345
Kurtzke scales revisited: the application of psychometric methods to clinical intuition
Hobart, J. (2000) · Brain · doi:10.1093/brain/123.5.1027 · Cited by 328
Assessing walking disability in multiple sclerosis
Kieseier, B. C., & Pozzilli, C. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458512444498 · Cited by 306
Repairing the human brain after stroke. II. Restorative therapies
Cramer, S. C. (2008) · Annals of Neurology · doi:10.1002/ana.21412 · Cited by 285
Lutterotti, A., Yousef, S., Sputtek, A., Stürner, K. H., Stellmann, J.-P., Breiden, P., Reinhardt, S., Schulze, C., Bester, M., Heesen, C., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006168 · Cited by 281
Chard, D. T. (2002) · Brain · doi:10.1093/brain/awf240 · Cited by 280
Audoin, B., Ibarrola, D., Ranjeva, J., Confort‐Gouny, S., Malikova, I., Ali‐Chérif, A., Pelletier, J., & Cozzone, P. (2003) · Human Brain Mapping · doi:10.1002/hbm.10128 · Cited by 267
Drake, A., Weinstock-Guttman, B., Morrow, S., Hojnacki, D., Munschauer, F., & Benedict, R. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458509354552 · Cited by 263
Cohen, J. A., Reingold, S. C., Polman, C. H., & Wolinsky, J. S. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70059-5 · Cited by 233
Self-citationGold, S. M., Heesen, C., Schulz, H., Guder, U., Mönch, A., Gbadamosi, J., Buhmann, C., & Schulz, K. H. (2001) · Multiple Sclerosis Journal · doi:10.1177/135245850100700208 · Cited by 183
Assessment and impact of cognitive impairment in multiple sclerosis: An overview
Macías Islas, M. Á., & Ciampi, E. (2019) · Biomedicines · doi:10.3390/biomedicines7010022 · Cited by 144
SUMOWSKI, J. F., CHIARAVALLOTI, N., WYLIE, G., & DELUCA, J. (2009) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617709090912 · Cited by 132
Simons, L. E., Logan, D. E., Chastain, L., & Cerullo, M. (2010) · The Clinical Journal of Pain · doi:10.1097/ajp.0b013e3181cf59fb · Cited by 127
Fleming, J., Hernandez, G., Hartman, L., Maksimovic, J., Nace, S., Lawler, B., Risa, T., Cook, T., Agni, R., Reichelderfer, M., et al. (2019) · Multiple Sclerosis Journal · doi:10.1177/1352458517736377 · Cited by 74
Diagnosis and Management of Progressive Multiple Sclerosis
Macaron, G., & Ontaneda, D. (2019) · Biomedicines · doi:10.3390/biomedicines7030056 · Cited by 70
Sativex® and clinical–neurophysiological measures of spasticity in progressive multiple sclerosis
Leocani, L., Nuara, A., Houdayer, E., Schiavetti, I., Del Carro, U., Amadio, S., Straffi, L., Rossi, P., Martinelli, V., Vila, C., et al. (2015) · Journal of Neurology · doi:10.1007/s00415-015-7878-1 · Cited by 66
Disruption of neurite morphology parallels MS progression
Spanò, B., Giulietti, G., Pisani, V., Morreale, M., Tuzzi, E., Nocentini, U., Francia, A., Caltagirone, C., Bozzali, M., & Cercignani, M. (2018) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000502 · Cited by 58
Tilling, K., Lawton, M., Robertson, N., Tremlett, H., Zhu, F., Harding, K., Oger, J., & Ben-Shlomo, Y. (2016) · Health Technology Assessment · doi:10.3310/hta20810 · Cited by 43
Redefining functionality and treatment efficacy in multiple sclerosis
Foley, J. F., & Brandes, D. W. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a99bc2 · Cited by 34
Gold, S. M., Schulz, H., Stein, H., Solf, K., Schulz, K.-H., & Heesen, C. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.10.020 · Cited by 24
Helmlinger, B., Seebacher, B., Ropele, S., Hechenberger, S., Heschl, B., Reishofer, G., Jordan, S., Tinauer, C., Wurth, S., Valsasina, P., et al. (2025) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2025.123426 · Cited by 4
Metadata
- Authors
- Cutter, G. R.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-05-01
- Volume
- 122
- Issue
- 5
- Pages
- 871-882
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2104878804
- Cited by
- 1,190
- References
- 33
- FWCI
- 12.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.